Rxsight Stock Buy Hold or Sell Recommendation
| RXST Stock | USD 25.84 0.62 2.46% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Rxsight is 'Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Rxsight given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Rxsight, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Rxsight Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide. Note, we conduct extensive research on individual companies such as Rxsight and provide practical buy, sell, or hold advice based on investors' constraints. Rxsight. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Rxsight |
Execute Rxsight Buy or Sell Advice
The Rxsight recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Rxsight. Macroaxis does not own or have any residual interests in Rxsight or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Rxsight's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Rxsight Trading Alerts and Improvement Suggestions
| Rxsight generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 139.93 M. Net Loss for the year was (27.45 M) with profit before overhead, payroll, taxes, and interest of 98.94 M. | |
| Rxsight currently holds about 128.62 M in cash with (16.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.65. | |
| Over 91.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Disposition of 7000 shares by Fountain Tamara of Rxsight at 25.7145 subject to Rule 16b-3 |
Rxsight Returns Distribution Density
The distribution of Rxsight's historical returns is an attempt to chart the uncertainty of Rxsight's future price movements. The chart of the probability distribution of Rxsight daily returns describes the distribution of returns around its average expected value. We use Rxsight price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Rxsight returns is essential to provide solid investment advice for Rxsight.
| Mean Return | -0.73 | Value At Risk | -6.46 | Potential Upside | 3.73 | Standard Deviation | 3.06 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Rxsight historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Rxsight Stock Institutional Investors
The Rxsight's institutional investors refer to entities that pool money to purchase Rxsight's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Divisadero Street Capital Management, Lp | 2024-12-31 | 812.5 K | Deutsche Bank Ag | 2024-12-31 | 657.2 K | Crédit Agricole S.a. | 2024-12-31 | 592 K | Royal Bank Of Canada | 2024-12-31 | 508.5 K | No Street Gp Lp | 2024-12-31 | 500 K | Gilder Gagnon Howe & Co Llc | 2024-12-31 | 425.3 K | Df Dent & Co Inc | 2024-12-31 | 422.4 K | Atika Capital Management Llc | 2024-12-31 | 408.6 K | Northern Trust Corp | 2024-12-31 | 403.4 K | Ra Capital Management, Llc | 2024-12-31 | 3.7 M | Blackrock Inc | 2024-12-31 | 3 M |
Rxsight Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (1.3M) | (2.1M) | (7.6M) | (2.7M) | (5.0M) | (5.2M) | |
| Investments | 18.1M | (80.0M) | 42.3M | (22.1M) | (99.3M) | (94.3M) | |
| Change In Cash | 5.6M | 10.7M | (12.6M) | (2.2M) | 7.1M | 7.4M | |
| Free Cash Flow | (37.7M) | (46.6M) | (61.2M) | (46.4M) | (22.4M) | (23.5M) | |
| Depreciation | 4.0M | 4.0M | 4.0M | 4.2M | 3.6M | 3.2M | |
| Other Non Cash Items | 85K | 493K | (101K) | (3.9M) | (7.7M) | (8.1M) | |
| Capital Expenditures | 2.5M | 1.9M | 2.4M | 4.8M | 5.4M | 3.9M | |
| Net Income | 27.6M | (48.7M) | (66.8M) | (48.6M) | (27.5M) | (26.1M) | |
| End Period Cash Flow | 14.5M | 25.2M | 12.6M | 10.4M | 17.5M | 16.3M |
Rxsight Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Rxsight or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Rxsight's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Rxsight stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.64 | |
β | Beta against Dow Jones | 0.91 | |
σ | Overall volatility | 2.86 | |
Ir | Information ratio | -0.21 |
Rxsight Volatility Alert
Rxsight exhibits very low volatility with skewness of -0.97 and kurtosis of 2.05. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Rxsight's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Rxsight's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Rxsight Fundamentals Vs Peers
Comparing Rxsight's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Rxsight's direct or indirect competition across all of the common fundamentals between Rxsight and the related equities. This way, we can detect undervalued stocks with similar characteristics as Rxsight or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Rxsight's fundamental indicators could also be used in its relative valuation, which is a method of valuing Rxsight by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Rxsight to competition |
| Fundamentals | Rxsight | Peer Average |
| Return On Equity | -0.12 | -0.31 |
| Return On Asset | -0.0919 | -0.14 |
| Profit Margin | (0.20) % | (1.27) % |
| Operating Margin | (0.21) % | (5.51) % |
| Current Valuation | 820.74 M | 16.62 B |
| Shares Outstanding | 40.49 M | 571.82 M |
| Shares Owned By Insiders | 5.05 % | 10.09 % |
| Shares Owned By Institutions | 91.19 % | 39.21 % |
| Number Of Shares Shorted | 2.41 M | 4.71 M |
| Price To Earning | 42.55 X | 28.72 X |
| Price To Book | 3.72 X | 9.51 X |
| Price To Sales | 7.48 X | 11.42 X |
| Revenue | 139.93 M | 9.43 B |
| Gross Profit | 98.94 M | 27.38 B |
| EBITDA | (23.76 M) | 3.9 B |
| Net Income | (27.45 M) | 570.98 M |
| Cash And Equivalents | 128.62 M | 2.7 B |
| Cash Per Share | 4.65 X | 5.01 X |
| Total Debt | 12.3 M | 5.32 B |
| Debt To Equity | 0.41 % | 48.70 % |
| Current Ratio | 11.54 X | 2.16 X |
| Book Value Per Share | 6.96 X | 1.93 K |
| Cash Flow From Operations | (16.95 M) | 971.22 M |
| Short Ratio | 4.62 X | 4.00 X |
| Earnings Per Share | (0.71) X | 3.12 X |
| Price To Earnings To Growth | 0.03 X | 4.89 X |
| Target Price | 44.8 | |
| Number Of Employees | 498 | 18.84 K |
| Beta | 1.22 | -0.15 |
| Market Capitalization | 1.05 B | 19.03 B |
| Total Asset | 318.56 M | 29.47 B |
| Retained Earnings | (622.1 M) | 9.33 B |
| Working Capital | 267.95 M | 1.48 B |
Note: Disposition of 7000 shares by Fountain Tamara of Rxsight at 25.7145 subject to Rule 16b-3 [view details]
Rxsight Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Rxsight . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Rxsight Buy or Sell Advice
When is the right time to buy or sell Rxsight? Buying financial instruments such as Rxsight Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Rxsight in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Marketing Thematic Idea Now
Marketing
Companies providing marketing and public relation (PR) services as well as news and media distribution. The Marketing theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marketing Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Rxsight Stock Analysis
When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.